JPRN-UMIN000007894已完成未知
Switch to Vildagliptin, oral hypoglycemic agent therapy, from Liraglutide injection - SWITCH-1
Department of Medicine, Shiga University of Medical Science0 个研究点目标入组 15 人开始时间: 2012年5月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)severe hepatic dysfunction(ALT or AST more than 2.5times of normal value) 2)undergo dialysis 3)NYHA Classification:3 or 4 4)pregnancy 5)past history of the allergy to Vildagliptin 6)severe infection, before operation, severe trauma 7)patients who need insulin therapy 8)patients who are judged to be ineligible by the investigator for some reason
研究者
相似试验
已完成
不适用
Switch to Vildagliptin, oral hypoglycemic agent therapy, from Liraglutide injection (SWITCH-2)Type2 DiabetesJPRN-UMIN000008944Department of Medicine, Shiga University of Medical Science15
已完成
不适用
Switch to oral hypoglycemic agent therapy from insulin injectioJPRN-UMIN000007051Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science,60
已完成
不适用
Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetesType 2 diabetesNutritional, Metabolic, EndocrineISRCTN35210312Okhotsk-kai Hospital (Japan)36
进行中（未招募）
不适用
Effect of adding vildagliptin to start of insulin treatment in combination with metformin in patients with type 2 diabetes - Effect of adding vildagliptin to insulin treatmentpatients with type 2 diabetes, failing on maximal oral glucose-lowering drugs, starting on insulin therapy in combination with standard metfromin (2 x 850)MedDRA version: 9.1Level: LLTClassification code 10012594Term: DiabetesEUCTR2009-010967-18-NLniversity Medical Centre Utrecht40
已完成
3 期
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetesDiabetesNL-OMON37974Academisch Medisch Centrum40